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ABSTRACT 
Objective: The objective of the present study includes isolation, characterization and screening of anticancerous activity against B16F10 cell line 
using isolated marine microalgae Chlorella sp._PR1.  
Methods: In this study, marine microalgae Chlorella sp._PR1 isolated and cultured using f/2 medium and anticancerous activity was assayed using 
MTT assay.  
Results: The DMSO extract of Chlorella sp._PR1 was exhibit anticancerous activity against murine melanoma B16F10 cell line. The extract exhibit 
reduction of cell viability up to 56% with 2µg/ml concentration. IC50 were calculated and was found that Chlorella sp._PR1 need 5.5 μg/ml of the 
compounds to reduce the murine melanoma B16F10 cell viability by 50%. Fluorescence activated cell sorting (FACS) analysis revealed that 
Chlorella sp._PR1 extract (8 µg/ml) brought significant inhibition (p<0.01) of the G0-G1 and the S phase. The extract did not seem to affect the G2
Conclusion: DMSO extract of Chlorella sp._PR1 (5.5 µg/ml) was found to be potent against murine melanoma B16F10 cell line.  
-M 
phase.  




According to American Cancer Society (Cancer facts and figure 
2014) it is estimated that the incidence of cancer in children and 
adolescent is increased. In 2014, it was estimated that there are 
15,780 new cases of cancer and among them 1960 deaths of children 
and adolescent occur due to cancer. A number of drugs were derived 
from the natural source such as plant and microorganisms against 
various different types of cancer (prostate cancer, breast cancer, 
lung cancer, colon cancer). The marine system consists of indefinite 
uncharacterized organisms that are producing secondary 
metabolites for their communication as well as defense purpose [1]. 
These secondary metabolites also have biological potentials such as 
anticancerous [2], antimicrobial [3,4], antiviral [5], antidiabetic [6], 
anti-inflammatory [7] etc. According to literature several 
anticancerous drugs were isolated from marine sources, among 
them some are in the clinical trial phase whereas some crossed the 
clinical phase and now are available in markets [8]. 
Microalgae are microscopic, and diverse group of eukaryotic 
organisms that can convert solar energy into chemical energy 
through photosynthesis. They evolve their own defense mechanisms 
by secreting toxic secondary metabolite, which is explored in 
anticancer studies [9,10]. These metabolites have played an 
important role in pharmaceutical industries. In the present study, 
marine microalgae were isolated from the Southern Ocean water 
sample. The marine Microalgae were identified through 
amplification of ITS region of ribosome. The microalgal extract with 
different concentration were screened for their anticancerous 
property conducting of MTT assay.  
MATERIALS AND METHODS 
Algae isolation and culturing 
Microalgae were isolated from the Southern Ocean (Indian sector) 
water sample. 250 ml of water sample was filtered through the 
membrane with pore size of 0.22 µm. After filtration, membrane was 
washed in 5 ml of autoclaved sea water. 30 μl of the above 5 ml were 
inoculated on 100 μl of f/2 medium [11] and incubated at 25 0C ± 
2 0C under light (56 µmol m-2 s-1
Morphological characterization of Microalgae 
). After 15 days, cultures were 
serially diluted and plated for axenic culture. 
Morphology of micro algal cells was done through light microscopy by 
simple wet mount method. The aliquot of each sample was placed in 
the centre of the clean glass slide and covered with a thin cover slips. 
The microalgae was examined under light microscope (Olympus, 
CH20) by 100 × objective lens and photographs were taken. Surface 
morphology of isolated Microalgae Chlorella sp. _PR1 was analyzed 
through SEM study. The sample was initially fixed with glutraldehyde 
and post fixed with Osmium tetraoxide. It was then dehydrated with 
ethanol and allowed to dry completely and was examined under the 
scanning electron microscope (JSM-6390LV, Jeol, Japan).  
PCR Amplification, sequencing and phylogenetic analysis 
DNA was isolated by CTAB method and DNA amplification of ITS 
region of ribosome was carried out using forward (5'-
GAAGTCGTAACAAGGTTTCC-3') and reverse (5'-TCCTGGTTA 
GTTTCTTTTCC-3') primer. Amplification condition was: initial 
denaturation of 950C for 4 min., followed by 35 cycle of denaturation 
at 940
Screening for anticancer activity 
C for 45 sec, 1 min at 60°C as annealing temperature, and 
extension at 72°C for 1 min and then 10 min final extension at 72ºC. 
PCR amplification was carried out in GeneAmp PCR 9700 (Applied 
Biosystem). The PCR product was then purified, sequenced 
(3130×Genetic analyzer, Applied Biosystem) and analyzed.  
Culturing of tumor cell line 
Highly metastatic murine melanoma cell line B16F10 was obtained 
from National Centre for Cell Science (NCCS), Pune, India. Cells were 
cultured and maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) containing 10% Fetal Bovine Serum (FBS), penicillin (100 
U/ml) and streptomycin (100 μg/ml). For subculture, the medium 
was removed and attached cells were harvested with pre-warmed 
(37°C) trypsin solution (0.125%). Subsequently, harvested cells 
were seeded in tissue culture plates with fresh media at 37°C in a 
humidified 5% CO2
Algal extract preparation 
 incubator. 
Algal cells were harvested in early log phase and centrifuged at 5000 
rpm for 10 min. The pellet was dried and stored at 4̊C for further 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491              Vol 6, Issue 10, 2014 
Innovare 
Academic Sciences 
Gupta et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 10, 517-519 
518 
use. 1 mg of dried algal powder of Chlorella sp._PR1 was dissolved in 
dimethyl sulphoxide (DMSO). The selected doses were 2, 4 and 8 
µg/ml and the corresponding doses of vehicle control were also 
tested to observe the effect of DMSO on the cells.  
Anticancer assay 
Incubation of treated B16F10 cells was carried out in 96-well plates 
at 37°C for 24 hrs. With various concentrations of microalgal 
extracts. MTT solution was added to each well (1.2 mg/ml) and 
incubated for 4hr. Plates were then centrifuged for 10 minutes at 
1000 rpm in the cold centrifuge. A volume of 175 µl from the 
supernatant was pipetted out and subsequently added with 175 µl of 
DMSO. The MTT-formazan product dissolved in DMSO was 
estimated by measuring absorbance at 540 nm in an ELISA plate 
reader. 
Statistical Analysis 
Statistical analysis was performed with SPSS 10.0 (one way ANOVA 
followed by Dunett t-test, where the significance level was set at 
0.001). Dunett t-test treats one group as a control and treats all 
other groups against it. 
Fluorescent activated cell sorter (FACS) study 
2 × 104
RESULTS AND DISCUSSION 
 B16/F10 melanoma cells, both for treated and control were 
harvested, washed with phosphate buffer saline (PBS), re suspended 
in sterile PBS. Cells were fixed in ice cold 100% methanol at l - 20°C 
for 1 hr. The cells were centrifuged at 5000 rpm for 10 min and the 
cell pellets were suspended in 1 ml of hypotonic buffer (0.5% Triton 
X-100 in PBS and 0.5 mg/ml RNase), and incubated at 37°C for 30 
min. Subsequently Propidium Iodide (PI) solution (50 mg/ml) was 
added, and the mixture was allowed to stand for 1 hr in darkness. 
Fluorescence that emitted from the PI–DNA complex was 
quantitated after excitation of the fluorescent dye by (FACS Calibur 
with sorter, BD, San Jose, CA, USA, Fig. A) using Cell Quest software 
(BD, San Jose, CA, USA) equipped with a 488 nm argon laser and a 
525 ± 10 nm band pass emission filter. Fluorescence was captured 
on a FL2H channel with linear amplification. 
Microscopic study of Microalgae via light and scanning electron 
microscopy 
Isolated Microalgae were examined with light microscope 100 × 
magnification and it was found that they are unicellular, size varied 
from 3-5 micron and the chloroplast was cup shaped (figure 1a). 
Surface morphology of marine isolate Chlorella sp._PR1 is single cell 
size of (6.23 µm × 4.51 µm) (figure 1b). 
 
 
Fig. 1: Morphological study of marine isolate Chlorella sp._PR1 
a) Light microscopy at 100 × magnification; b) Scanning 
Electron Microscopy at 10,000 × magnification 
 
Phylogenetic analysis 
Multiple sequence alignment (MSA) of the ITS sequences was 
aligned by CLUSTALW embedded in MEGA 5.0. The phylogram 
(Figure 2) provided the confirmation that the isolated Microalgae 
belonged to Chlorella sp. Based on sequence homology and 
phylogenetic analysis Chlorella sp._PR1 belongs to Chlorella vulgaris 
(Accession no. 51095187). 
GC content of Chlorella sp._PR1 is 56.7%. Genes located in low GC 
region (55-65% GC) shows evidence of shorter intron and less 




Fig. 2: Phylogenetic analysis based on ITS region of isolated 
algal strain (Chlorella sp. _PR1) and other sequences already 
deposited and available at NCBI. 
 
Anticancerous assay 
The cytotoxicity assay revealed that the microalgal extracts reduced 
the viability of B16F10 cells in a dose and time dependent manner. 
The doses 2, 4 and 8 µg/ml and the corresponding doses of vehicle 
control were also tested to observe the effect of DMSO on the cell 
viability. A representative figure of cell morphology of B16F10 cell 
line with and without treatment has been shown in Figure 3. 
 
 
Fig. 3: Morphology of murine melanoma cell line B16F10 (a) 
without any treatment; (b) after treatment of Chlorella sp._PR1. 
 
 
Fig. 4: Inhibition of cell growth in B16F10 cells with Chlorella 
sp._PR1. Dose dependent reduction of cell viability with 
Chlorella sp._PR1 [*p<0.001]; Significant increase in inhibition 
of cell growth with Chlorella sp._PR1 [*p<0.001] in comparison 
to the corresponding dose of vehicle control. 
The extract of Chlorella sp._PR1 exhibited a sharp reduction 
[*p<0.001] of cell viability to 56% with 2 μg/ml after which the 
increase in the dose of the microalgal extract was associated with a 
gradual decrease of cell viability (Figure 4). The inhibition of cell 
growth was significantly more with the Chlorella sp._PR1 extract 
[*p<0.001] in comparison to the vehicle control (Figure 4). 
 
A similar study was done with hexane extract, ethyl acetate extract 
of Chlorella ovalis against HL-60 and murine melanoma B16F10 cell 
line and was found that, hexane extract effectively suppress the 
growth of HL-60 and B16F10 compared to control [12]. Two 
monogalactosyl diacylglycerols (MGDG) induces apoptosis in two 
genetically-matched immortal mouse epithelial cell lines [13]. The 
inhibition of cell growth was significantly more with the Chlorella 
sp._PR1 extract [*p<0.001] in comparison to the vehicle control. 
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IC50 of the microalgal extracts 
The IC50 values of Chlorella sp._PR1 extracts have been calculated 
from the cytotoxicity studies. This was found that Chlorella sp._PR1 
need 5.5 μg/ml of the compounds to reduce the murine melanoma 
B16F10 cell viability by 50%. 
FACS analysis 
In the present study, the murine melanoma B16F10 cells were 
treated with different doses (2, 4, 8 µg/ml) of Chlorella sp._PR1 
extract for 24 hrs and were consequently subjected to FACS analysis.  
The data obtained from FACS analysis revealed that the Chlorella 
sp._PR1 extract induced an apoptotic effect on the B16F10 cells in a 
dose dependent manner (Figure 5, 6). The comparative graphical 
representation depicts the significant rise (p<0.01) in the 
percentage of cells in the sub G1 phase of the cell cycle with increase 
in dose of the Chlorella sp._PR1 extract compared to the control cells 
without any treatment (Figure 5). The highest dose (8 µg/ml) 
brought significant inhibition (p<0.01) of the G0-G1 and the S phase. 
The extract did not seem to affect the G2-M phase.  
 
 
Fig. 5: Comparative representations of the cells (%) at different 
stages of the cell cycle with various doses of Chlorella sp._PR1. 
Extract (CE). The extract showed a significant dose dependent 
increase in the percentage of sub G1 cells (*p<0.01) in comparison 
to the control cells. Highest dose of CE (8 µg/ml) significantly 
inhibited G0-G1 and S phase (*p<0.01) of B16F10 cells. 
 
 
Fig. 6: FACS analysis showing dose dependent apoptotic effect of 
Chlorella sp._PR1 extract on cell cycle of B16F10 cells as 




In this study chlorella sp._PR1 was isolated from the Southern Ocean 
water sample (Indian sector). Chlorella sp._PR1 was found to be 
potent against murine melanoma B16F10 cell line with 5.5µg/ml 
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